Clinical trial

Effects of Henagliflozin on the Brain Function in T2DM Patients With Mild Cognitive Impairment: a Randomized, Parallel Controlled Clinical Trial

NCT06085703

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2024-04-01

PhaseNA

Study timeline

Study start (actual)2024-04-01Date precision: day

Registry last updated2025-07-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetes Mellitusunresolved

Mild Cognitive Impairmentunresolved

Interventions

HenagliflozinDRUG

GliclazideDRUG

Sponsors & collaborators

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical Schoollead sponsor

Mapped research locations

NanjingJiangsu, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06085703 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.